Monitoring Tumor Response with Radiolabeled Nucleoside Analogs in a Hepatoma-Bearing Mouse Model Early after Doxisome® Treatment

Molecular Imaging and Biology

Volumn 15, Issue 3, 2013, Pages 326-335

  Wu, Chun Yi ^a   Chou, Lin Shan ^a   Chan, Pei Chia ^a   Ho, Chung Hsien ^a   Lin, Ming Hsien ^b   Shen, Chih Chieh ^c   Liu, Ren Shyan ^a,d   Lin, Wuu Jyh ^e   Wang, Hsin Ell ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

18F FLT; Doxisome ; Hepatoma; PET; Therapeutic efficacy

Indexed keywords

3' FLUOROTHYMIDINE F 18; DOXISOME; DOXORUBICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL DEATH; DEOXYCYTIDINE; DIDEOXYNUCLEOSIDES; DISEASE MODELS, ANIMAL; DOXORUBICIN; ENDOCYTOSIS; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MULTIMODAL IMAGING; POLYETHYLENE GLYCOLS; POSITRON-EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84877750964     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-012-0604-9     Document Type: Article

References (28)

1. 18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 31:1659-1672
2. 18F-FLT versus 18F-FDG. J Nucl Med 44:1426-1431
3. 18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res 65:10104-10112
4. 18F]fluorothymidine imaging. Clin Cancer Res 17:1099-1110
5. 131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire. Br J Cancer 77:385-390
6. 124I]iododeoxyuridine. Cancer Res 60:624-635
7. Kriss JP, Maruyama Y, Tung LA, Bond SB, Revesz L (1963) The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man. Cancer Res 23:260-268
8. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468
9. Alberts DS, Muggia FM, Carmichael J et al (2004) Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. Semin Oncol 31:53-90
10. Kim DW, Ahn DS, Oh YH et al (2006) A new class of SN2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules. J Am Chem Soc 128:16394-16397
11. 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. Cancer Biother Radiopharm 24:453-460
12. Nickoloff BJ, Chaturvedi V, Bacon P et al (2000) Id-1 delays senescence but does not immortalize keratinocytes. J Biol Chem 275:27501-27504
13. Tournier I, Bernuau D, Poliard A, Schoevaert D, Feldmann G (1987) Detection of albumin mRNAs in rat liver by in situ hybridization: usefulness of paraffin embedding and comparison of various fixation procedures. J Histochem Cytochem 35:453-459
14. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44:213-221
15. Porenta G, Cherry S, Czernin J et al (1999) Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 26:1465-1474
16. Rubin PJ, Lee DS, Davila-Roman VG et al (1996) Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am J Cardiol 78:1230-1235
17. van den Hoff J, Burchert W, Wolpers HG, Meyer GJ, Hundeshagen H (1996) A kinetic model for cardiac PET with [1-carbon-11]-acetate. J Nucl Med 37:521-529
18. 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912-1921
19. 18F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment. Nucl Med Biol 36:163-169
20. Chen YL, Eriksson S, Chang ZF (2010) Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage. J Biol Chem 285:27327-27335
21. Kratz F, Muller IA, Ryppa C, Warnecke A (2008) Prodrug strategies in anticancer chemotherapy. ChemMedChem 3:20-53
22. Leonard RC, Williams S, Tulpule A, Levine AM, Oliveros S (2009) Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). Breast 18:218-224
23. Lombardi G, Zustovich F, Farinati F et al (2011) Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 study. Cancer 117:125-133
24. 188Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Cancer Biother Radiopharm 26:373-380
25. Lee WC, Chang CH, Ho CL et al (2011) Early detection of tumor response by FLT/microPET Imaging in a C26 murine colon carcinoma solid tumor animal model. J Biomed Biotechnol 2011:535902
26. Dresdale A, Bonow RO, Wesley R et al (1983) Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas. Cancer 52:51-60
27. Shields AF (2012) PET imaging of tumor growth: not as easy as it looks. Clin Cancer Res 18:1189-1191
28. 18F]FLT-PET imaging does not always "light up" proliferating tumor cells. Clin Cancer Res 18:1303-1312